![Dirk Beher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dirk Beher
Vorstandsvorsitzender bei FundaMental Pharma GmbH
Aktive Positionen von Dirk Beher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Direktor/Vorstandsmitglied | 11.04.2024 | - |
Vorstandsvorsitzender | 11.04.2024 | - |
Karriereverlauf von Dirk Beher
Ehemalige bekannte Positionen von Dirk Beher
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | 01.10.2012 | 06.10.2023 |
Vorstandsvorsitzender | 01.01.2014 | 06.10.2023 | |
Technik-/Wissenschafts-/F&E-Leiter | 01.10.2012 | 01.01.2014 | |
Gründer | 01.10.2012 | 06.10.2023 |
Ausbildung von Dirk Beher
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistik
International
Deutschland | 3 |
Schweiz | 2 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Asceneuron SA
![]() Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Health Technology |
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Health Technology |
- Börse
- Insiders
- Dirk Beher
- Erfahrung